The contents of 1 ampoule of Hemase ® is diluted in 0.5 ml of 0.9% sodium chloride solution. The resulting solution contains a dose corresponding to 5000 ME. The drug is administered parabulbarically or subconjunctivally up to 10 injections per course.
To rinse the anterior chamber of the eye with massive fibrin efflorescence in the anterior chamber or hyphae, the lyophilized substance (5000 ME) is diluted in 1 ml of 0.9% sodium chloride solution, after which 0.2 ml (1000 ME) or 0.1 ml (500 ME) of the resulting solution and diluted to 0.5 ml with 0.9% sodium chloride solution.
For intravitreal administration, 5000 ME lyophilisate is diluted in 1 ml of a 0.9% solution of sodium chloride, taken 0.1 ml (500 ME) of the solution obtained and diluted with 0.1-0.2 ml of 0.9% sodium chloride solution. The resulting volume (0.2-0.3 ml) is administered intravitreally once.
In the presence of fibrin exudate and hyphema after cataract extraction recommended or subconjunctival administration parabulbarly Gemaza® preparation and introduction into the anterior chamber. When vitreous hemorrhage, retinal vascular occlusive lesions of the retina and optic nerve shown parabulbarnom Gemaza® preparation. With hemophthalmia of various etiologies and fibrinoid syndrome, intravitreal administration of the drug is possible.
For the prevention of adhesions in the postoperative period when operations Gemaza® antiglaucomatous drug is diluted in the proportions indicated for subconjunctival injection, and injected into the filter pad in the early postoperative period, in an amount of 1-3 injections (at the discretion of the surgeon).